Home » Newsletters » BioWorld

BioWorld

Nov. 8, 2004

View Archived Issues

Stock Winners and Losers For The Week

Correction

Public Financing Of Biotechnology: October 2004

Other Financings Of Public Biotechnology Companies:October 2004

Venture Capital And Corporate Investments In Biotechnology Companies: October 2004

Money Raised By Month

Plexxikon Scores As PPAR Cloud Fails To Deter Wyeth

Money Raised Year To Date

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...